EIT inside: elisa 800VIT

EIT inside: elisa 800<sup>VIT</sup>

The world´s first mechanical ventilator with Swisstom´s EIT technology inside. To product

See what really matters!

See what really matters!

Silent SpacesTM are areas within the lungs that receive neither much air nor much attention in other EIT images.
Download SilentSpaces Definitions

YouTube Channel

YouTube Channel

Find new video introductions with and about EIT YouTube

Swisstom makes lung function visible without x-rays

Swisstom AG, located in Landquart, Switzerland, develops and manufactures innovative medical devices. Our new lung function monitor enables life-saving treatments for patients in intensive care and during general anesthesia.

Unlike traditional tomography, Swisstom´s bedside imaging is based on non-radiating principles: Electrical Impedance Tomography (EIT). To date, no comparable devices can show such regional organ function continuously and in real-time at the patient’s bedside.

Swisstom creates its competitive edge by passionate leadership in non-invasive tomography with the goal to improve individual lives and therapies.

First there was a vision

“When I was still ventilating patients in the ICU and saw many of them die, it was my dearest wish to look right into their chest to better understand what was going on in their lungs. Until recently, this dream remained unfulfilled …”

Dr. med. Stephan Böhm


Acqusistion of Swisstom
Swisstom AG in Landquart, Switzerland was acquired by Sentec AG in Therwil, Switzerland on July 20, 2018. Swisstom was founded 2009 and has developed non-invasive, regional lung function monitoring devices based on Electrical Impedance Tomography (EIT).
The focus of Swisstom will remain unchanged under the umbrella of Sentec AG. The technology and product portfolio will be further strengthened, industrialized and made ready for a successful market introduction in the near future. Swisstom AG remains located in Landquart, the staff will be build up and managed by the EIT Branch Manager, Mr. Guido Schelling.
Both companies believe that the combination of EIT and transcutaneous sensor technologies may further advance patient monitoring in critical care settings.